Accedi a banche dati online | Convegnodetail
mail
Anteprima di stampa
 
 

2nd Annual Oligonucleotides for CNS Summit

Evvnt Promotion / evvnt
-
13.06.2022 - 15.06.2022  Hilton Boston Logan Airport, One Hotel Drive, 02128 Boston, Massachusetts, USA
Time: 7:00 AM - 3:15 PM
 
Temi della conferenza
With Biogen investing millions in Ionis' efforts to weaponize ASOs against SMA, Stoke Therapeutics collaborating with Acadia Pharmaceuticals to supercharge the development of RNA-Based treatments for genetic neurodevelopmental diseases and the global oligonucleotide therapeutics market set to experience unprecedented growth, there’s never been a more opportune moment for biopharma to expand their oligonucleotide pipelines into the untapped potential of the CNS.
Professional congress organizer (PCO)
Hanson Wade
 

Informazioni ed Iscrizioni:

https://go.evvnt.com/1054624-2?pid=4832
Ms. Stephanie Nketia
 
Categorie
Medicina General
Lingua
Inglese
Quote del Congresso
USD 2599.00 - USD 4797.00
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."

European Public Health Association (EUPHA)Swiss Tropical and Public Health InstituteEuropean Health Forum GasteinÖsterreichische Akademie der ÄrzteAMREF - African Medical and Research FoundationOÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation Anästhesie in Entwicklungsländern e. V.AGEM - Arbeitsgemeinschaft Ethnologie und Medizin